SANGAMO THERAPEUTICS, INC - SGMO
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | Head of Research & Technology | F | D | 1,630.0 | 0.1743 | 284.11 | 113,654.0 | View | |
| May 27, 2026 | Principal Accounting Officer | F | D | 1,919.0 | 0.1743 | 334.48 | 235,292.0 | View | |
| May 27, 2026 | SVP-CHIEF DEVELOPMENT OFFICER | F | D | 4,036.0 | 0.1743 | 703.47 | 328,733.0 | View | |
| May 27, 2026 | SVP, CHIEF LEGAL OFFICER, SECY | F | D | 4,036.0 | 0.1743 | 703.47 | 647,370.0 | View | |
| May 27, 2026 | PRESIDENT, CEO AND DIRECTOR | F | D | 12,613.0 | 0.1743 | 2,198.45 | 1,895,043.0 | View | |
| Apr 23, 2026 | Head of Research & Technology | S | D | 69,827.0 | 0.2534 | 17,694.16 | 115,284.0 | View | |
| Apr 23, 2026 | SVP-CHIEF DEVELOPMENT OFFICER | S | D | 345,942.0 | 0.2578 | 89,183.85 | 332,769.0 | View | |
| Apr 03, 2026 | PRESIDENT, CEO AND DIRECTOR | A | A | 2,500,000.0 | 0.0 | 0.0 | 2,500,000.0 | View | |
| Apr 03, 2026 | SVP, CHIEF LEGAL OFFICER, SECY | A | A | 800,000.0 | 0.0 | 0.0 | 800,000.0 | View | |
| Apr 03, 2026 | SVP-CHIEF DEVELOPMENT OFFICER | A | A | 800,000.0 | 0.0 | 0.0 | 800,000.0 | View | |
| Apr 03, 2026 | Head of Research & Technology | A | A | 225,000.0 | 0.0 | 0.0 | 225,000.0 | View | |
| Apr 03, 2026 | Principal Accounting Officer | A | A | 225,000.0 | 0.0 | 0.0 | 225,000.0 | View |